Trial · NCT07909447
Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder
NCT07909447, Not applicable, Completed, Uskudar University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder. Trials, record NCT07909447. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909447
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder
- NCT number
- NCT07909447
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 70 participants, actual
- Lead sponsor
- Uskudar University
- Conditions
- Substance Use Disorder (SUD), Anxiety, Depression
- Interventions
- Qigong Exercises
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Trait Anxiety Scores Measured by the State-Trait Anxiety Inventory (STAI-II) | Baseline, Week 3 (immediately post-intervention), and Week 4 (one-week follow-up) | Trait anxiety was assessed using the Trait Anxiety subscale of the State-Trait Anxiety Inventory (STAI-II), developed by Spielberger et al. The STAI-II measures an individual's general tendency to experience anxiety, regardless of specific situations or circumstances. The scale consists of 20 items rated on a four-point Likert scale. Total scores range from 20 to 80, with higher scores indicating greater trait anxiety. |
| Primary | Change in Depression Scores Measured by the Beck Depression Inventory (BDI) | Baseline, Week 3 (immediately post-intervention), and Week 4 (one-week follow-up) | Depression levels were assessed using the Beck Depression Inventory (BDI), developed by Beck et al. The BDI is a 21-item self-report instrument designed to assess the severity of depressive symptoms. Each item is scored on a four-point scale ranging from 0 to 3. Total scores range from 0 to 63, with higher scores indicating greater severity of depressive symptoms. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909447
GET https://conductscience.org/api/trials/v1/NCT07909447/registered